185 related articles for article (PubMed ID: 3092971)
1. Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on evaluation of cervical cancer screening programmes.
Br Med J (Clin Res Ed); 1986 Sep; 293(6548):659-64. PubMed ID: 3092971
[TBL] [Abstract][Full Text] [Related]
2. 1991 cervical screening recommendations: a working group report.
Paul C; Bagshaw S; Bonita R; Durham G; Fitzgerald NW; Jones RW; Marshall B; McAvoy BR
N Z Med J; 1991 Jul; 104(915):291-5. PubMed ID: 1906587
[TBL] [Abstract][Full Text] [Related]
3. Predicting mortality from cervical cancer after negative smear test results.
van Oortmarssen GJ; Habbema JD; van Ballegooijen M
BMJ; 1992 Aug; 305(6851):449-51. PubMed ID: 1392957
[TBL] [Abstract][Full Text] [Related]
4. Screening for squamous cervical cancer--the duration of low risk following negative results in cervical cytology test: introduction. IARC Working Group on Cervical Cancer Screening.
IARC Sci Publ; 1986; (76):15-24. PubMed ID: 3570401
[No Abstract] [Full Text] [Related]
5. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancers diagnosed after negative results on cervical cytology: perspective in the 1980s.
Mitchell H; Medley G; Giles G
BMJ; 1990 Jun; 300(6740):1622-6. PubMed ID: 2372641
[TBL] [Abstract][Full Text] [Related]
7. Pap test--with or without vaginal smear?
Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
[TBL] [Abstract][Full Text] [Related]
8. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
[TBL] [Abstract][Full Text] [Related]
9. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
10. Risk of cervical cancer after a negative Pap smear.
Viikki M; Pukkala E; Hakama M
J Med Screen; 1999; 6(2):103-7. PubMed ID: 10444730
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the effectiveness of cervical cancer screening: a case-control study in Miyagi, Japan.
Makino H; Sato S; Yajima A; Komatsu S; Fukao A
Tohoku J Exp Med; 1995 Mar; 175(3):171-8. PubMed ID: 7792786
[TBL] [Abstract][Full Text] [Related]
12. Risk of cervical cancer following negative smears in Maribo County, Denmark, 1966-1982.
Lynge E; Poll P
IARC Sci Publ; 1986; (76):69-86. PubMed ID: 3570417
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer screening in a rural population of Zimbabwe.
Thistle PJ; Chirenje ZM
Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
[TBL] [Abstract][Full Text] [Related]
14. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
[TBL] [Abstract][Full Text] [Related]
15. Screening interval and risk of invasive squamous cell cervical cancer.
Miller MG; Sung HY; Sawaya GF; Kearney KA; Kinney W; Hiatt RA
Obstet Gynecol; 2003 Jan; 101(1):29-37. PubMed ID: 12517642
[TBL] [Abstract][Full Text] [Related]
16. Cervical screening attendance and its effectiveness in a rural population in China.
Zhang ZF; Parkin DM; Yu SZ; Esteve J; Yang XZ; Day NE
Cancer Detect Prev; 1989; 13(5-6):337-42. PubMed ID: 2743356
[TBL] [Abstract][Full Text] [Related]
17. Cost-effective policies for cervical cancer screening. An international review.
Fahs MC; Plichta SB; Mandelblatt JS
Pharmacoeconomics; 1996 Mar; 9(3):211-30. PubMed ID: 10160098
[TBL] [Abstract][Full Text] [Related]
18. An examination of the role of opportunistic smear taking in the NHS cervical screening programme using data from the CSEU cervical screening cohort study.
Blanks RG; Moss SM; Coleman DA; Swerdlow AJ
BJOG; 2007 Nov; 114(11):1408-13. PubMed ID: 17803716
[TBL] [Abstract][Full Text] [Related]
19. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
Açikgöz A; Ergör G
Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer screening. Organised screening to avoid unnecessary conisation.
Prescrire Int; 2010 Aug; 19(108):172-7, 179. PubMed ID: 20939454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
